CV
CVS
CVS · NYSE
$96.75 -0.46% (-$0.45)
1M +1.09%
Market Cap $124.0B
P/E Ratio 25.28x
Div. Yield 2.74%
ROE 6.43%
Bulios Fair Price
$90.53
6.4% downside
Current Price
$96.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CVS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
73 /100
Cheap P/E 25.28x
P/B 1.56x
EV/EBITDA 14.09x
Growth
23 /100
Declining EPS growth 24.73%
Book val. growth 1.72%
Rev. growth 7.63%
Profitability
15 /100
Weak Gross margin 14.15%
FCF margin 2.83%
Net margin 1.18%
Quality
34 /100
Average ROIC 4.09%
Asset turnover 1.64x
ROE 6.43%
Debt
31 /100
High Debt/Equity 0.96x
Net debt/EBITDA 4.85x
Current ratio 0.87x
Stability
70 /100
Stable Beta 0.60x
Profitable years 6
Rev. volatility 3.38%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CVS
Online
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
J. David Joyner
Employees
259,500
Headquarters
Woonsocket
Upcoming events
04 NOV
Earnings
Upcoming earnings report